Document is current
Any future updates will be listed below
-
Authors
Grzmil, Michal
Boersema, Paul
Sharma, Ashish
Blanc, Alain
Imobersteg, Stefan
Pruschy, Martin
Picotti, Paola
Schibli, Roger
Behe, Martin https://orcid.org/0000-0002-1110-2665
-
Funding
Funding for this research was provided by:
Swiss Cancer Research Foundation (KFS-3960-08-2016-R, KFS-3960-08-2016-R, KFS-3960-08-2016-R)
- License Information
-
More Information
Article History
Received: 23 May 2022
Accepted: 17 August 2022
First Online: 31 August 2022
Declarations
:
: All animal experiments were performed in accordance with Swiss Animal Protection Laws.
: Not applicable.
: MB and RS are inventors of the patent WO2015/067473: Minigastrin analogue, in particular for use in CCK2 receptor positive tumor, diagnosis and/or treatment. No other potential conflict of interest relevant to this article was reported.
